Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph I Friedman

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 12, 2003
The course of functional decline in geriatric patients with schizophrenia: cognitive-functional and clinical symptoms as determinants of changePhilip D Harvey, Hillary Bertisch, Joseph I Friedman, et al.
Biological Psychiatry|February 16, 2006
RETRACTED: The Relationships Between White Matter Cerebral Metabolites and Clinical Manifestations in Geriatric Patients with Schizophrenia: A 4 Tesla Proton Magnetic Resonance Spectroscopy StudyJoseph I Friedman, Linda Chang, Nicholas Tsopelas, et al.
Journal of Clinical and Experimental Neuropsychology|April 6, 2002
Cortical and subcortical cognitive deficits in schizophrenia: convergence of classifications based on language and memory skill areasPhilip D Harvey, Patrick J Moriarty, Christopher Bowie, et al.
Journal of Clinical Psychopharmacology|May 7, 2005
The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophreniaJoseph I Friedman, Ramoncito Ocampo, Zeinab Elbaz, et al.
Journal of Clinical and Experimental Neuropsychology|February 18, 2006
Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophreniaPhilip D Harvey, Joseph I Friedman, Christopher Bowie, et al.
Schizophrenia Research|August 24, 2006
Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: retrospective comparison of first generation and second generation antipsychoticsLeonard White, Joseph I Friedman, Christopher R Bowie, et al.
Archives of General Psychiatry|May 14, 2003
White matter changes in schizophrenia: evidence for myelin-related dysfunctionKenneth L Davis, Daniel G Stewart, Joseph I Friedman, et al.
Biological Psychiatry|March 21, 2002
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophreniaJoseph I Friedman, David N Adler, Evelyn Howanitz, et al.
The American Journal of Psychiatry|August 3, 2002
Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidityJoseph I Friedman, Philip D Harvey, Susan R McGurk, et al.
JACC. Cardiovascular Imaging|October 18, 2014
Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patientsJoseph I Friedman, Cheuk Y Tang, Hans J de Haas, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 12, 2003
The course of functional decline in geriatric patients with schizophrenia: cognitive-functional and clinical symptoms as determinants of changePhilip D Harvey, Hillary Bertisch, Joseph I Friedman, et al.
Biological Psychiatry|February 16, 2006
RETRACTED: The Relationships Between White Matter Cerebral Metabolites and Clinical Manifestations in Geriatric Patients with Schizophrenia: A 4 Tesla Proton Magnetic Resonance Spectroscopy StudyJoseph I Friedman, Linda Chang, Nicholas Tsopelas, et al.
Journal of Clinical and Experimental Neuropsychology|April 6, 2002
Cortical and subcortical cognitive deficits in schizophrenia: convergence of classifications based on language and memory skill areasPhilip D Harvey, Patrick J Moriarty, Christopher Bowie, et al.
Journal of Clinical Psychopharmacology|May 7, 2005
The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophreniaJoseph I Friedman, Ramoncito Ocampo, Zeinab Elbaz, et al.
Journal of Clinical and Experimental Neuropsychology|February 18, 2006
Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophreniaPhilip D Harvey, Joseph I Friedman, Christopher Bowie, et al.
Schizophrenia Research|August 24, 2006
Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: retrospective comparison of first generation and second generation antipsychoticsLeonard White, Joseph I Friedman, Christopher R Bowie, et al.
Archives of General Psychiatry|May 14, 2003
White matter changes in schizophrenia: evidence for myelin-related dysfunctionKenneth L Davis, Daniel G Stewart, Joseph I Friedman, et al.
Biological Psychiatry|March 21, 2002
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophreniaJoseph I Friedman, David N Adler, Evelyn Howanitz, et al.
The American Journal of Psychiatry|August 3, 2002
Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidityJoseph I Friedman, Philip D Harvey, Susan R McGurk, et al.
JACC. Cardiovascular Imaging|October 18, 2014
Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patientsJoseph I Friedman, Cheuk Y Tang, Hans J de Haas, et al.
Pageof 4